The company brand and market position of Bang & Olufsen Medicom as an independent and innovative Drug Delivery Device partner is well known in the industry and our position has been further strengthened over the last 3-4 years as part of our strategic repositioning.
As a consequence of the final divestment from Bang & Olufsen in March 2015 it was also agreed that Medicom would remove the link to Bang & Olufsen in the company name.
With effect of 1 September 2015 Bang & Olufsen Medicom will change name to Medicom Innovation Partner to signal our dedicated position as an innovation partner for our customers and at the same time keep a strong link to our Medicom heritage. "With our new Medicom Innovation Partner name we simplify our brand message to the market – but beside that we will stay the same and continue to develop our market position and deliver on our solid growth strategy”, states CEO Morten Nielsen. “We have experienced a strong market interest for our integrated device strategy, concept, development and low-volume manufacturing services and we have enjoyed an increasing interest to join the success of Medicom”, Morten Nielsen continues.
There are no further commercial, financial or legal implications of the name change.
*******
For further questions, please contact CEO Morten Nielsen on telephone (+45) 20 75 37 01
_______________________________________